November 15, 2022Blood
Bone Marrow Fibrosis Changes Do Not Correlate with Efficacy Outcomes in Myelofibrosis: Analysis of More Than 300 JAK Inhibitor-Naïve Patients Treated with Momelotinib or Ruxolitinib
Authors
Discussion
Loading...
Member takes
Overview
Key Points
Key points are not available for this paper at this time.
Cite This Study
Oh et al. (2022) studied this question.